|
1
|
Ananyeva NM, Tjurmin AV, Berliner JA, et
al: Oxidized LDL mediates the release of fibroblast growth
factor-1. Arterioscler Thromb Vasc Biol. 17:445–453. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D, Liu L, Chen H, Sawamura T,
Ranganathan S and Mehta JL: LOX-1 mediates oxidized low-density
lipoprotein-induced expression of matrix metalloproteinases in
human coronary artery endothelial cells. Circulation. 107:612–617.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cai H and Harrison DG: Endothelial
dysfunction in cardiovascular diseases: The role of oxidant stress.
Circ Res. 87:840–844. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chisolm GM 3rd and Chai Y: Regulation of
cell growth by oxidized LDL. Free Radic Biol Med. 28:1697–1707.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chai YC, Binion DG, Macklis R and Chisolm
GM 3rd: Smooth muscle cell proliferation induced by oxidized
LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from
cells not extracellular matrix. Vascul Pharmacol. 38:229–237. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shen CM, Mao SJ, Huang GS, Yang PC and Chu
RM: Stimulation of smooth muscle cell proliferation by ox-LDL- and
acetyl LDL-induced macrophage-derived foam cells. Life Sci.
70:443–452. 2001. View Article : Google Scholar
|
|
7
|
Hsieh CC, Yen MH, Yen CH and Lau YT:
Oxidized low density lipoprotein induces apoptosis via generation
of reactive oxygen species in vascular smooth muscle cells.
Cardiovasc Res. 49:135–145. 2001. View Article : Google Scholar
|
|
8
|
Chang PY, Luo S, Jiang T, et al: Oxidized
low-density lipoprotein downregulates endothelial basic fibroblast
growth factor through a pertussis toxin-sensitive G-protein
pathway: Mediator role of platelet-activating factor-like
phospholipids. Circulation. 104:588–593. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CH, Jiang W, Via DP, et al: Oxidized
low-density lipoproteins inhibit endothelial cell proliferation by
suppressing basic fibroblast growth factor expression. Circulation.
101:171–177. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Higashi Y, Peng T, Du J, et al: A
redox-sensitive pathway mediates oxidized LDL-induced
downregulation of insulin-like growth factor-1 receptor. J Lipid
Res. 46:1266–1277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao P, Wang XM, Qian DH, et al: Induction
of oxidative stress by oxidized LDL via meprinα-activated epidermal
growth factor receptor in macrophages. Cardiovasc Res. 97:533–543.
2013. View Article : Google Scholar
|
|
12
|
Nishio E, Arimura S and Watanabe Y:
Oxidized LDL induces apoptosis in cultured smooth muscle cells: a
possible role for 7-ketocholesterol. Biochem Biophys Res Commun.
223:413–418. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen G, Delarue F, Burcklé C, Bouzhir L,
Giller T and Sraer JD: Pivotal role of the renin/prorenin receptor
in angiotensin II production and cellular responses to renin. J
Clin Invest. 109:1417–1427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nguyen G: Renin/prorenin receptors. Kidney
Int. 69:1503–1506. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oliver JA: Receptor-mediated actions of
renin and prorenin. Kidney Int. 69:13–15. 2006. View Article : Google Scholar
|
|
16
|
Funke-Kaiser H, Zollmann FS, Schefe JH and
Unger T: Signal transduction of the (pro)renin receptor as a novel
therapeutic target for preventing end-organ damage. Hypertens Res.
33:98–104. 2010. View Article : Google Scholar
|
|
17
|
Sakoda M, Ichihara A, Kaneshiro Y, et al:
(Pro)renin receptor-mediated activation of mitogen-activated
protein kinases in human vascular smooth muscle cells. Hypertens
Res. 30:1139–1146. 2007. View Article : Google Scholar
|
|
18
|
Feldt S, Batenburg WW, Mazak I, et al:
Prorenin and renin-induced extracellular signal-regulated kinase
1/2 activation in monocytes is not blocked by aliskiren or the
handle-region peptide. Hypertension. 51:682–688. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Wongamorntham S, Kasting J, et
al: Renin increases mesangial cell transforming growth factor-beta1
and matrix proteins through receptor-mediated, angiotensin
II-independent mechanisms. Kidney Int. 69:105–113. 2006. View Article : Google Scholar
|
|
20
|
Huang Y, Noble NA, Zhang J, Xu C and
Border WA: Renin-stimulated TGF-beta1 expression is regulated by a
mitogen-activated protein kinase in mesangial cells. Kidney Int.
72:45–52. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu X: Oxidized low density lipoprotein
activates ERK 1/2 pathway via (pro)renin receptor in human
umbilical vein endothelial cells. Chinese Journal of Integrative
Medicine on Cardio/Cerebrovascular Disease. 10:1235–1237. 2013.In
Chinese.
|
|
22
|
Greco CM, Camera M, Facchinetti L, et al:
Chemotactic effect of prorenin on human aortic smooth muscle cells:
a novel function of the (pro)renin receptor. Cardiovasc Res.
95:366–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaneshiro Y, Ichihara A, Sakoda M, et al:
Slowly progressive, angiotensin II-independent glomerulosclerosis
in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol.
18:1789–1795. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abassi Z, Winaver J and Feuerstein GZ: The
biochemical pharmacology of renin inhibitors: implications for
translational medicine in hypertension, diabetic nephropathy and
heart failure: expectations and reality. Biochem Pharmacol.
78:933–940. 2009. View Article : Google Scholar : PubMed/NCBI
|
